Although IL-22 possesses definite immunomodulatory properties and tissue-protective effects, mainly via inhibiting apoptosis and promoting proliferation of epithelial cells, these same effects have also been involved in pathological states such as psoriasis, rheumatoid arthritis, and malignant tumors (99, 100). Here, IL22 is linked to cancer.